Genmab | Umsatzkosten



Cost Of Sales Veränderung Datum
Agios Pharmaceuticals USD 1.7M 617K 2025-06
Almirall EUR 195.09M 100.89M 2025-06
Amarin USD 16.89M 18.51M 2025-03
Amgen USD 3.01B 406M 2025-06
argenx SE USD 110.75M 29.94M 2025-06
AstraZeneca USD 2.47B 232M 2025-06
Bayer EUR 4.36B 1.26B 2025-06
BioMarin Pharmaceutical USD 154.94M 3.38M 2025-06
Demant DKK 2.71B 46M 2025-06
Exelixis USD 19.47M 298K 2025-07
Fresenius Medical Care EUR 3.58B 120M 2025-06
Galapagos EUR 4.71M 9.02M 2025-06
Genmab DKK 57M 15M 2025-06
GlaxoSmithKline GBP 2.16B 241M 2025-06
GN Store Nord DKK 1.93B 136M 2025-06
GRIFOLS EUR 1.15B 56.19M 2025-06
Hikma Pharmaceutical USD 895M 82M 2024-12
Insmed USD 29.34M 8.06M 2025-06
Lonza CHF 2.47B 532M 2024-12
Merck EUR 2.23B 93M 2025-06
Novartis USD 3.32B 95M 2025-06
Regeneron Pharmaceuticals USD 530.2M 264.7M 2025-06
Roche Holding CHF 4.13B 393.5M 2024-12
Sanofi EUR 2.99B 103M 2025-06
UCB EUR 901M 50M 2024-12


Genmab Umsatzkosten - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Sep 2025.